EUVIMEDEUVIMED entdecken
Crossref

Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer

Sambit Kumar Patra, Sambit Kumar Pradhan, Zahid Alim Ansari, Bijesh Kumar Biswal

Medical Oncology · 11.12.2025 · 43 (1)

DOI: 10.1007/s12032-025-03178-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, online erschienen am 11.12.2025. Verfasst von Sambit Kumar Patra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology, 769008, Rourkela, Odisha, India. Hauptthemen laut MEDLINE: Cisplatin, Carcinoma, Non-Small-Cell Lung, Quinazolines, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin resistance poses a significant barrier to effective chemotherapy in non-small cell lung cancer, often driven by epithelial-mesenchymal transition regulators such as ZEB2. In this study, we explored the therapeutic potential of Evodiamine (Evo), a natural alkaloid derived from Evodia rutaecarpa, to overcome cisplatin resistance in A549 lung cancer cells. Using MTT assay, we evaluated the cytotoxic effects of Evo on both A549 parental and A549 cisplatin-resistant(A549CR) cells (IC-50 4 µM & 2 µM respectively), observing a dose-dependent reduction in cell viability. Quantitative real-time PCR analysis revealed that Evo treatment significantly downregulated ZEB2 expression along with key drug-resistance genes, suggesting its role in reversing the resistant phenotype. In silico molecular docking and network analysis further supported strong binding interactions between Evo and ZEB2, TGM2, MMP1, CD24, PDK4, highlighting its potential as a direct inhibitor. By further evaluating anti-proliferative, anti-migratory property with apoptotic inducing potential of Evo, we found there is a significant effect on A549 and A549CR cells. Together, these findings demonstrate that ZEB-2 can be an effective target of Evo mediating cisplatin resistance pathways and sensitize resistant lung cancer cells to cisplatin, providing a promising combinatorial therapeutic strategy to enhance NSCLC treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinCarcinoma, Non-Small-Cell LungQuinazolinesDrug Resistance, NeoplasmLung NeoplasmsHumansA549 CellsGene Expression Regulation, NeoplasticZinc Finger E-box Binding Homeobox 2Antineoplastic AgentsMolecular Docking SimulationApoptosisCell ProliferationCell Line, Tumor

Stichwörter der Autor:innen

Cisplatin resistanceComputational analysisEvodiamineLung cancerPhytotherapy

Substanzen

CisplatinevodiamineQuinazolinesZinc Finger E-box Binding Homeobox 2Antineoplastic AgentsZEB2 protein, human

Autor:innen und Institutionen

  • Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology, 769008, Rourkela, Odisha, India.
  • Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology, 769008, Rourkela, Odisha, India. biswalb@nitrkl.ac.in.

Zitieren

APA

Patra, S. K., Pradhan, S. K., Ansari, Z. A., & Biswal, B. K. (2025). Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer. Medical Oncology, 43(1). https://doi.org/10.1007/s12032-025-03178-2

Vancouver

Patra SK, Pradhan SK, Ansari ZA, Biswal BK. Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer. Medical Oncology. 2025;43(1). doi:10.1007/s12032-025-03178-2

BibTeX
@article{Patra2025,
  author = {Patra, Sambit Kumar and Pradhan, Sambit Kumar and Ansari, Zahid Alim and Biswal, Bijesh Kumar},
  title = {Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer},
  journal = {Medical Oncology},
  year = {2025},
  volume = {43},
  number = {1},
  doi = {10.1007/s12032-025-03178-2}
}
Kostenlos starten →